XML 85 R74.htm IDEA: XBRL DOCUMENT v3.21.2
Segment Reporting - Reconciliation of Segment Profits to Income before Taxes (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Segment Reporting Information [Line Items]        
Profits $ 5,266 $ 2,706 $ 9,970 $ 8,408
Interest income 7 9 27 48
Interest expense (196) (203) (597) (624)
Amortization     (1,231) (1,393)
Depreciation     (1,148) (1,210)
Research and development (2,445) (3,349) (9,177) (7,609)
Restructuring costs (107) (113) (487) (265)
Operating Segments        
Segment Reporting Information [Line Items]        
Profits 9,111 7,484 24,079 20,583
Operating Segments | Pharmaceutical segment        
Segment Reporting Information [Line Items]        
Profits 8,606 7,026 22,450 19,235
Operating Segments | Animal Health segment        
Segment Reporting Information [Line Items]        
Profits 505 459 1,629 1,347
Operating Segments | Other segment        
Segment Reporting Information [Line Items]        
Profits 0 (1) 0 1
Corporate, Non-Segment        
Segment Reporting Information [Line Items]        
Profits 141 (28) 29 135
Segment Reconciling Items        
Segment Reporting Information [Line Items]        
Interest income 7 9 27 48
Interest expense (196) (203) (597) (624)
Amortization (360) (406) (1,231) (1,393)
Depreciation (358) (367) (1,031) (1,105)
Research and development (2,312) (3,231) (8,775) (7,251)
Restructuring costs (107) (113) (487) (265)
Other unallocated, net $ (660) $ (439) $ (2,044) $ (1,720)